27 Evaluation of the Cheshire and Merseyside cardiovascular disease prevention pilot service

<h3>Background</h3> Early identification of cardiovascular disease (CVD) allows for timely intervention, which improves cardiovascular-related health outcomes. The service was established to address incidental coronary artery calcification identified during lung screening. This service currently offers lifestyle modification and drug therapy, thereby alleviating the burden on primary care. <h3>Aim</h3> The aim of the service evaluation was to evaluate the effectiveness of the Cheshire and Merseyside CVD Prevention Service. <h3>Methods</h3> Service usage data was collated from electronic patient record systems. Metrics included the number of patients identified at increased risk of CVD, types of interventions provided, and patient feedback. Data was collected over an eight-month period from October 2023 to May 2024. <h3>Results</h3> Early findings indicate that the service has successfully reduced primary care referrals requiring immediate action from 64% to 36% in 2023/24. 698 patients were reviewed, of these, 307 (43.9%) received lifestyle modification referrals. 535 patients (77.1%) accepted lipid-lowering therapy. Further investigations were required for 138 patients (19.8%), including undiagnosed hypertension, impaired glucose regulation and dysrhythmia. 51 patients (7.3%) required an urgent referral due to clinical signs and symptoms. Patient feedback was largely positive, with 97.4% of respondents indicating they would recommend the service to friends and family. <h3>Conclusion</h3> The service has successfully reduced primary care referrals 64% to 36%, demonstrating its effectiveness in managing CVD risk factors and alleviating the burden on primary care. A significant number of patients (698) were reviewed, with a substantial proportion receiving lifestyle modification (43.9%) and accepting lipid-lowering therapy (77.1%), highlighting patient engagement and implementation of both lifestyle and pharmacological interventions. Patient feedback indicates high satisfaction and confidence in the care provided.

Authors

Institutions

Publication Details

Published
2024-09-30
DOI
https://doi.org/10.1136/heartjnl-2024-bacpr.27
Primary Topic
Clinical practice guidelines implementation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

27 Evaluation of the Cheshire and Merseyside cardiovascular disease prevention pilot service

Zoe McIntosh, Elaine Gossage, Greg Irving, Joanne Dilworth et al.
Clinical practice guidelines implementation
article

27 Evaluation of the Cheshire and Merseyside cardiovascular disease prevention pilot service

Zoe McIntosh, Elaine Gossage, Greg Irving, Joanne Dilworth, Dannielle Burns, Nathan Hilton
article en

Abstract

<h3>Background</h3> Early identification of cardiovascular disease (CVD) allows for timely intervention, which improves cardiovascular-related health outcomes. The service was established to address incidental coronary artery calcification identified during lung screening. This service currently offers lifestyle modification and drug therapy, thereby alleviating the burden on primary care. <h3>Aim</h3> The aim of the service evaluation was to evaluate the effectiveness of the Cheshire and Merseyside CVD Prevention Service. <h3>Methods</h3> Service usage data was collated from electronic patient record systems. Metrics included the number of patients identified at increased risk of CVD, types of interventions provided, and patient feedback. Data was collected over an eight-month period from October 2023 to May 2024. <h3>Results</h3> Early findings indicate that the service has successfully reduced primary care referrals requiring immediate action from 64% to 36% in 2023/24. 698 patients were reviewed, of these, 307 (43.9%) received lifestyle modification referrals. 535 patients (77.1%) accepted lipid-lowering therapy. Further investigations were required for 138 patients (19.8%), including undiagnosed hypertension, impaired glucose regulation and dysrhythmia. 51 patients (7.3%) required an urgent referral due to clinical signs and symptoms. Patient feedback was largely positive, with 97.4% of respondents indicating they would recommend the service to friends and family. <h3>Conclusion</h3> The service has successfully reduced primary care referrals 64% to 36%, demonstrating its effectiveness in managing CVD risk factors and alleviating the burden on primary care. A significant number of patients (698) were reviewed, with a substantial proportion receiving lifestyle modification (43.9%) and accepting lipid-lowering therapy (77.1%), highlighting patient engagement and implementation of both lifestyle and pharmacological interventions. Patient feedback indicates high satisfaction and confidence in the care provided.

University of Liverpool (GB), Edge Hill University (GB), Liverpool Heart and Chest Hospital NHS Trust (GB), Liverpool Heart and Chest Hospital (GB)
Good health and well-being
Openalex Percentile: Top 75%
Clinical practice guidelines implementation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.